Bhide, Y., Dong, W., Meijerhof, T., de Vries-Idema, J., Niesters, H. G., & Huckriede, A. (2020). Characterization of humoral immune responses and degree of protection induced by influenza vaccine in cotton rats: Effects of low vaccine dose and single vs booster vaccination. Immunity, inflammation and disease, 8(3), 279-291. https://doi.org/10.1002/iid3.303

van Eijk, M., Hillaire, M. L. B., Rimmelzwaan, G. F., Rynkiewicz, M. J., White, M. R., Hartshorn, K. L., Hessing, M., Koolmees, P. A., Tersteeg, M. H., van Es, M. H., Meijerhof, T., Huckriede, A., & Haagsman, H. P. (2019). Enhanced Antiviral Activity of Human Surfactant Protein D by Site-Specific Engineering of the Carbohydrate Recognition Domain. Frontiers in Immunology, 10, [2476]. https://doi.org/10.3389/fimmu.2019.02476

Bhide, Y., Dong, W., Gribonika, I., Voshart, D., Meijerhof, T., de Vries-Idema, J., Norley, S., Guilfoyle, K., Skeldon, S., Engelhardt, O. G., Boon, L., Christensen, D., Lycke, N., & Huckriede, A. (2019). Cross-Protective Potential and Protection-Relevant Immune Mechanisms of Whole Inactivated Influenza Virus Vaccines Are Determined by Adjuvants and Route of Immunization. Frontiers in Immunology, 10, [646]. https://doi.org/10.3389/fimmu.2019.00646

Dong, W., Bhide, Y., Sicca, F., Meijerhof, T., Guilfoyle, K., Engelhardt, O. G., Boon, L., de Haan, C. A. M., Carnell, G., Temperton, N., de Vries-Idema, J., Kelvin, D., & Huckriede, A. (2018). Cross-Protective Immune Responses Induced by Sequential Influenza Virus Infection and by Sequential Vaccination With Inactivated Influenza Vaccines. Frontiers in Immunology, 9, [2312]. https://doi.org/10.3389/fimmu.2018.02312

Dong, W., Bhide, Y., Marsman, S., Holtrop, M., Meijerhof, T., de Vries-Idema, J., de Haan, A., & Huckriede, A. (2018). Monophosphoryl Lipid A-Adjuvanted Virosomes with Ni-Chelating Lipids for Attachment of Conserved Viral Proteins as Cross-Protective Influenza Vaccine. Biotechnology Journal, 13(4), [1700645]. https://doi.org/10.1002/biot.201700645

Herrera-Rodriguez, J., Meijerhof, T., Niesters, H. G., Stjernholm, G., Hovden, A-O., Sørensen, B., Ökvist, M., Sommerfelt, M. A., & Huckriede, A. (2018). A novel peptide-based vaccine candidate with protective efficacy against influenza A in a mouse model. Virology, 515, 21-28. https://doi.org/10.1016/j.virol.2017.11.018

Patil, H. P., Herrera Rodriguez, J., de Vries-Idema, J., Meijerhof, T., Frijlink, H. W., Hinrichs, W. L. J., & Huckriede, A. (2017). Adjuvantation of Pulmonary-Administered Influenza Vaccine with GPI-0100 Primarily Stimulates Antibody Production and Memory B Cell Proliferation. Vaccines, 5(3). https://doi.org/10.3390/vaccines5030019

Patil, H. P., Murugappan, S., de Vries-Idema, J., Meijerhof, T., de Haan, A., Frijlink, H. W., Wilschut, J., Hinrichs, W. L. J., & Huckriede, A. (2015). Comparison of adjuvants for a spray freeze-dried whole inactivated virus influenza vaccine for pulmonary administration. European Journal of Pharmaceutics and Biopharmaceutics, 93, 231-241. https://doi.org/10.1016/j.ejpb.2015.04.004

van de Wall, S., Walczak, M., van Rooij, N., Hoogeboom, B-N., Meijerhof, T., Nijman, H. W., & Daemen, T. (2015). Tattoo Delivery of a Semliki Forest Virus-Based Vaccine Encoding Human Papillomavirus E6 and E7. Vaccines, 3(2), 221-238. https://doi.org/10.3390/vaccines3020221

Draghiciu, O., Nijman, H. W., Hoogeboom, B. N., Meijerhof, T., & Daemen, T. (2015). Sunitinib depletes myeloid-derived suppressor cells and synergizes with a cancer vaccine to enhance antigen-specific immune responses and tumor eradication. OncoImmunology, 4(3), [989764]. https://doi.org/10.4161/2162402X.2014.989764

Keijzer, C., Haijema, B. J., Meijerhof, T., Voorn, P., de Haan, A., Leenhouts, K., van Roosmalen, M. L., van Eden, W., & Broere, F. (2014). Inactivated influenza vaccine adjuvanted with Bacterium-like particles induce systemic and mucosal influenza A virus specific T-cell and B-cell responses after nasal administration in a TLR2 dependent fashion. Vaccine, 32(24), 2904-2910. https://doi.org/10.1016/j.vaccine.2014.02.019

Ip, P., Boerma, A., Regts, J., Meijerhof, T., Wilschut, J., Nijman, H. W., & Daemen, T. (2014). Alphavirus-based Vaccines Encoding Nonstructural Proteins of Hepatitis C Virus Induce Robust and Protective T-cell Responses. Molecular Therapy, 22(4), 881-890. https://doi.org/10.1038/mt.2013.287

Patil, H. P., Murugappan, S., Ter Veer, W., Meijerhof, T., De Haan, A., Frijlink, H. W., Wilschut, J., Hinrichs, W. L. J., & Huckriede, A. (2014). Evaluation of monophosphoryl lipid A as adjuvant for pulmonary delivered influenza vaccine. Journal of controlled release : official journal of the Controlled Release Society, 174(1), 51-62. https://doi.org/10.1016/j.jconrel.2013.11.013

Kamphuis, T., Stegmann, T., Meijerhof, T., Wilschut, J., & de Haan, A. (2013). A virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A provides protection against viral challenge without priming for enhanced disease in cotton rats. Influenza and other respiratory viruses, 7(6), 1227-1236. https://doi.org/10.1111/irv.12112

Budimir, N., de Haan, A., Meijerhof, T., Gostick, E., Price, D. A., Huckriede, A., & Wilschut, J. (2013). Heterosubtypic cross-protection induced by whole inactivated influenza virus vaccine in mice: Influence of the route of vaccine administration. Influenza and other respiratory viruses, 7(6), 1202-1209. https://doi.org/10.1111/irv.12142

Murugappan, S., Patil, H. P., Kanojia, G., ter Veer, W., Meijerhof, T., Frijlink, H. W., Huckriede, A., & Hinrichs, W. L. J. (2013). Physical and immunogenic stability of spray freeze-dried influenza vaccine powder for pulmonary delivery: Comparison of inulin, dextran, or a mixture of dextran and trehalose as protectants. European Journal of Pharmaceutics and Biopharmaceutics, 85(3 PART A), 716-725. https://doi.org/10.1016/j.ejpb.2013.07.018

Budimir, N., de Haan, A., Meijerhof, T., Waijer, S., Boon, L., Gostick, E., Price, D. A., Wilschut, J., & Huckriede, A. (2013). Critical Role of TLR7 Signaling in the Priming of Cross-Protective Cytotoxic T Lymphocyte Responses by a Whole Inactivated Influenza Virus Vaccine. PLoS ONE, 8(5), [e63163]. https://doi.org/10.1371/journal.pone.0063163

Kamphuis, T., Shafique, M., Meijerhof, T., Stegmann, T., Wilschut, J., & de Haan, A. (2013). Efficacy and safety of an intranasal virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A in mice and cotton rats. Vaccine, 31(17), 2169-2176. https://doi.org/10.1016/j.vaccine.2013.02.043

Shafique, M., Meijerhof, T., Wilschut, J., & de Haan, A. (2013). Evaluation of an Intranasal Virosomal Vaccine against Respiratory Syncytial Virus in Mice: Effect of TLR2 and NOD2 Ligands on Induction of Systemic and Mucosal Immune Responses. PLoS ONE, 8(4), [e61287]. https://doi.org/10.1371/journal.pone.0061287

de Haan, A., Haijema, B. J., Voorn, P., Meijerhof, T., van Roosmalen, M. L., & Leenhouts, K. (2012). Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration. Vaccine, 30(32), 4884-4891. https://doi.org/10.1016/j.vaccine.2012.04.032

Kamphuis, T., Meijerhof, T., Stegmann, T., Lederhofer, J., Wilschut, J., & de Haan, A. (2012). Immunogenicity and Protective Capacity of a Virosomal Respiratory Syncytial Virus Vaccine Adjuvanted with Monophosphoryl Lipid A in Mice. PLoS ONE, 7(5), [e36812]. https://doi.org/10.1371/journal.pone.0036812

Budimir, N., Huckriede, A., Meijerhof, T., Boon, L., Gostick, E., Price, D. A., Wilschut, J., & de Haan, A. (2012). Induction of Heterosubtypic Cross-Protection against Influenza by a Whole Inactivated Virus Vaccine: The Role of Viral Membrane Fusion Activity. PLoS ONE, 7(1), [e30898]. https://doi.org/10.1371/journal.pone.0030898

Budimir, N., Meijerhof, T., Wilschut, J., Huckriede, A., & de Haan, A. (2010). The role of membrane fusion activity of a whole inactivated influenza virus vaccine in (re)activation of influenza-specific cytotoxic T lymphocytes. Vaccine, 28(52), 8280-8287. https://doi.org/10.1016/j.vaccine.2010.10.007

Stegmann, T., Kamphuis, T., Meijerhof, T., Goud, E., de Haan, A., & Wilschut, J. (2010). Lipopeptide-adjuvanted respiratory syncytial virus virosomes: A safe and immunogenic non-replicating vaccine formulation. Vaccine, 28(34), 5543-5550. https://doi.org/10.1016/j.vaccine.2010.06.041

Moesker, B., Rodenhuis-Zybert, I. A., Meijerhof, T., Wilschut, J., & Smit, J. M. (2010). Characterization of the functional requirements of West Nile virus membrane fusion. Journal of general virology, 91, 389-393. https://doi.org/10.1099/vir.0.015255-0